Your browser doesn't support javascript.
loading
MRI-based Deep Learning Assessment of Amyloid, Tau, and Neurodegeneration Biomarker Status across the Alzheimer Disease Spectrum.
Lew, Christopher O; Zhou, Longfei; Mazurowski, Maciej A; Doraiswamy, P Murali; Petrella, Jeffrey R.
Afiliação
  • Lew CO; From the Department of Radiology, Division of Neuroradiology, Alzheimer Disease Imaging Research Laboratory (C.O.L., J.R.P.), and Neurocognitive Disorders Program, Departments of Psychiatry and Medicine (P.M.D.), Duke University Medical Center, DUMC-Box 3808, Durham, NC 27710-3808; and Duke Institut
  • Zhou L; From the Department of Radiology, Division of Neuroradiology, Alzheimer Disease Imaging Research Laboratory (C.O.L., J.R.P.), and Neurocognitive Disorders Program, Departments of Psychiatry and Medicine (P.M.D.), Duke University Medical Center, DUMC-Box 3808, Durham, NC 27710-3808; and Duke Institut
  • Mazurowski MA; From the Department of Radiology, Division of Neuroradiology, Alzheimer Disease Imaging Research Laboratory (C.O.L., J.R.P.), and Neurocognitive Disorders Program, Departments of Psychiatry and Medicine (P.M.D.), Duke University Medical Center, DUMC-Box 3808, Durham, NC 27710-3808; and Duke Institut
  • Doraiswamy PM; From the Department of Radiology, Division of Neuroradiology, Alzheimer Disease Imaging Research Laboratory (C.O.L., J.R.P.), and Neurocognitive Disorders Program, Departments of Psychiatry and Medicine (P.M.D.), Duke University Medical Center, DUMC-Box 3808, Durham, NC 27710-3808; and Duke Institut
  • Petrella JR; From the Department of Radiology, Division of Neuroradiology, Alzheimer Disease Imaging Research Laboratory (C.O.L., J.R.P.), and Neurocognitive Disorders Program, Departments of Psychiatry and Medicine (P.M.D.), Duke University Medical Center, DUMC-Box 3808, Durham, NC 27710-3808; and Duke Institut
Radiology ; 309(1): e222441, 2023 10.
Article em En | MEDLINE | ID: mdl-37815445
ABSTRACT
Background PET can be used for amyloid-tau-neurodegeneration (ATN) classification in Alzheimer disease, but incurs considerable cost and exposure to ionizing radiation. MRI currently has limited use in characterizing ATN status. Deep learning techniques can detect complex patterns in MRI data and have potential for noninvasive characterization of ATN status. Purpose To use deep learning to predict PET-determined ATN biomarker status using MRI and readily available diagnostic data. Materials and Methods MRI and PET data were retrospectively collected from the Alzheimer's Disease Imaging Initiative. PET scans were paired with MRI scans acquired within 30 days, from August 2005 to September 2020. Pairs were randomly split into subsets as follows 70% for training, 10% for validation, and 20% for final testing. A bimodal Gaussian mixture model was used to threshold PET scans into positive and negative labels. MRI data were fed into a convolutional neural network to generate imaging features. These features were combined in a logistic regression model with patient demographics, APOE gene status, cognitive scores, hippocampal volumes, and clinical diagnoses to classify each ATN biomarker component as positive or negative. Area under the receiver operating characteristic curve (AUC) analysis was used for model evaluation. Feature importance was derived from model coefficients and gradients. Results There were 2099 amyloid (mean patient age, 75 years ± 10 [SD]; 1110 male), 557 tau (mean patient age, 75 years ± 7; 280 male), and 2768 FDG PET (mean patient age, 75 years ± 7; 1645 male) and MRI pairs. Model AUCs for the test set were as follows amyloid, 0.79 (95% CI 0.74, 0.83); tau, 0.73 (95% CI 0.58, 0.86); and neurodegeneration, 0.86 (95% CI 0.83, 0.89). Within the networks, high gradients were present in key temporal, parietal, frontal, and occipital cortical regions. Model coefficients for cognitive scores, hippocampal volumes, and APOE status were highest. Conclusion A deep learning algorithm predicted each component of PET-determined ATN status with acceptable to excellent efficacy using MRI and other available diagnostic data. © RSNA, 2023 Supplemental material is available for this article.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva / Aprendizado Profundo Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva / Aprendizado Profundo Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article